瘦素對大鼠肝纖維化的信號轉(zhuǎn)導(dǎo)調(diào)控及槲寄生堿的干預(yù)作用
[Abstract]:Objective To study the signal transduction mechanism and the intervention effect of leptin in the control of hepatic fibrosis in rats. Methods The model of hepatic fibrosis induced by CCl4 was studied. Forty-five rats were randomly divided into three groups: control group, model group and drug intervention group. The control group did not do any treatment, the free diet, the drinking water, the model group and the mistletoe treatment group were respectively injected with 40% CCl4-vegetable oil solution 2 ml/ kg, twice a week for 8 weeks. In the 9th week of the experiment, the treated group was given a total of 8g/ (kg 路 d) of mistletoe in rats, and the model group was given an equal dose of normal saline for 8 weeks. All animals were sacrificed at the 17-week cervical dislocation, and the left anterior lobe of the liver was removed. The effect of mistletoe on the morphology of hepatic fibrosis in rats with hepatic fibrosis was observed by HE staining and MASSON staining. The effect of mistletoe on the leptin and leptin receptor in rat hepatic stellate cells was observed by immunohistochemistry. The levels of JAK2, STAT3 protein and JAK2 and STAT3 protein were detected by Western Blot method. Results The results suggested that the liver fibrosis model of the rat was successful, and the mistletoe had the effect of blocking and reversing the hepatic fibrosis. Immunohistochemistry staining showed that the mistletoe significantly inhibited the expression of leptin and leptin receptor in the model rats compared with the model group. Western Blot showed that the expression of JAK2 and STAT3 in the normal control group was the least; the expression of JAK2 and STAT3 in the model group was significantly lower; and the expression of JAK2 and STAT3 in the drug-treated group was significantly reduced. Conclusion The mistletoe can effectively reverse the rat liver fibrosis, and the mechanism of action may be accomplished by down-regulating the expression of leptin and leptin receptor in rat liver tissue, and further affecting the signal pathway of JAK2/ STAT3.
【作者單位】: 首都醫(yī)科大學(xué)實驗動物部;首都醫(yī)科大學(xué)病理生理教研室;
【基金】:國家自然科學(xué)基金資助項目(81272757) 北京市屬高等學(xué)校創(chuàng)新團隊建設(shè)與教師職業(yè)發(fā)展計劃項目(IDHT20150502)
【分類號】:R575.2
【參考文獻】
相關(guān)期刊論文 前4條
1 高連印,車念聰,付修文,錢英;槲芪散治療慢性乙型病毒性肝炎30例療效分析[J];北京中醫(yī);2001年03期
2 王學(xué)江,錢英,豐平,文朝陽,姜大巍;槲芪散對肝癌前病變血清同功酶影響的研究[J];北京中醫(yī)藥大學(xué)學(xué)報;2000年S1期
3 文朝陽;史爭鳴;李霞;豐平;劉樹紅;王學(xué)江;;槲寄生總堿和多糖對黃曲霉菌毒素誘發(fā)大鼠肝癌前病變時血清同工酶含量的影響[J];中國藥理學(xué)與毒理學(xué)雜志;2009年03期
4 陳柏年,楊官娥,漆小梅,李青山;槲寄生抗腫瘤有效成分研究進展[J];中國新藥雜志;2005年10期
【共引文獻】
相關(guān)期刊論文 前10條
1 張秋云;丁相海;劉紹能;章紅英;錢英;黃娟;高連印;付修文;杜宇瓊;譚勇;;調(diào)肝顆粒劑對CCl_4慢性肝損傷大鼠肝功能及肝組織保護作用的實驗研究[J];北京中醫(yī)藥;2008年06期
2 豐平;徐大鵬;劉樹紅;李向利;文朝陽;;調(diào)肝顆粒劑防治大鼠肝癌前病變的病理研究[J];北京中醫(yī)藥;2010年08期
3 孔凡青;周立社;閆巧梅;高麗君;閆秀英;;槲寄生堿對人肝癌細(xì)胞SMMC-7721生長抑制作用的研究[J];包頭醫(yī)學(xué)院學(xué)報;2007年04期
4 宋洪杰;曹麗君;;海利升注射液輔助治療癌癥患者9例臨床療效觀察[J];當(dāng)代醫(yī)學(xué);2010年01期
5 孫長崗;劉瑞娟;孟肖路;;海利升注射液聯(lián)合化療治療中晚期NSCLC療效觀察[J];當(dāng)代醫(yī)學(xué);2010年06期
6 曹源;胡曉松;;PDGF介導(dǎo)的信號通路在肝纖維化肝星狀細(xì)胞活化增殖過程中的作用[J];重慶醫(yī)學(xué);2013年33期
7 朱云;程e,
本文編號:2347241
本文鏈接:http://sikaile.net/yixuelunwen/xiaohjib/2347241.html